Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Bought by New York Life Investment Management LLC

New York Life Investment Management LLC lifted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 6.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,764 shares of the company’s stock after buying an additional 659 shares during the quarter. New York Life Investment Management LLC’s holdings in Acadia Healthcare were worth $837,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in ACHC. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth about $24,157,000. OFI Invest Asset Management boosted its holdings in shares of Acadia Healthcare by 290.5% in the 3rd quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock valued at $21,990,000 after buying an additional 246,322 shares in the last quarter. Jennison Associates LLC grew its position in shares of Acadia Healthcare by 26.1% in the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after buying an additional 238,114 shares during the last quarter. California Public Employees Retirement System raised its stake in Acadia Healthcare by 112.6% during the 3rd quarter. California Public Employees Retirement System now owns 368,382 shares of the company’s stock worth $25,901,000 after acquiring an additional 195,130 shares in the last quarter. Finally, Kingdon Capital Management L.L.C. purchased a new stake in Acadia Healthcare in the third quarter valued at $12,058,000.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a research report on Thursday, April 25th. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. TD Cowen lifted their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research note on Monday, March 4th. Finally, TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $88.89.

Acadia Healthcare Trading Down 2.0 %

Shares of Acadia Healthcare stock opened at $66.06 on Thursday. The firm has a market cap of $6.13 billion, a price-to-earnings ratio of -471.86, a price-to-earnings-growth ratio of 1.96 and a beta of 1.31. Acadia Healthcare Company, Inc. has a 52-week low of $64.74 and a 52-week high of $87.77. The company’s 50-day simple moving average is $75.67 and its 200-day simple moving average is $77.32. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. During the same period in the prior year, the business posted $0.75 EPS. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. As a group, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.